$DIBS Balance Sheet | Understand Stock

$DIBS

$4.60 +$0.07 (1.55%) Close

$DIBS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash, current
Short-term investments
Accounts receivable, net of allowance for doubtful accounts of $75 and $72 at June 30, 2026 and December 31, 2025, respectively
Prepaid expenses
Receivables from payment processors and seller accounts
Other current assets
Total current assets
Restricted cash, non-current
Property and equipment, net
Operating lease right-of-use assets
Goodwill
Intangible assets, net
Other assets
Total assets

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Payables due to sellers
Accrued expenses
Operating lease liabilities, current
Other current liabilities
Total current liabilities
Operating lease liabilities, non-current
Other liabilities
Total liabilities
Redeemable convertible preferred stock (Series A, B, C, C-1, and D), $0.01 par value; zero and 57,771,864 shares authorized as of December 31, 2021 and 2020, respectively; zero and 19,243,795 shares issued and outstanding as of December 31, 2021 and 2020, respectively; and aggregate liquidation preference of zero and $301,300 as of December 31, 2021 and 2020, respectively
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000,000 shares authorized as of June 30, 2026 and December 31, 2025; zero shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.01 par value; 400,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 44,994,373 and 44,086,361 shares issued as of June 30, 2026 and December 31, 2025, respectively; and 33,615,293 and 36,848,301 outstanding as of June 30, 2026 and December 31, 2025, respectively
Treasury stock, at cost; 11,379,080 and 7,238,060 shares as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Common stock, outstanding (in shares)
Treasury stock, common (in shares)

Comments